Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD is getting closer

<< Previous

Bullboard Posts

Next >>

Comment by Johnandrose22on Nov 27, 2024 9:10pm

155 Views

Post# 36334861

RE:RE:RE:RE:BTD is getting closer

Just speculating here...Mr. White made clear in a recent interview that data from a base of 75 patients in the study would be "statistically significant"....If I am not mistaken, 3 month data from patients 72-75 has yet to be compiled until the end of Q4....could the holdup on BTD application have to do with pending and "significant" data?

Despite this possibility...I am disappointed, too.

<< Previous

Bullboard Posts

Next >>

Twelve Labs partners with AWS to revolutionize video search with AI